What you Need to Know About Biosimilar Medicinal Products

European Commission Consensus Information Document: What you Need to Know About Biosimilar Medicinal Products.

To view the full report, please click here.

IQVIA - Assessing the Biosimilar Void 30 October 2023 While biosimilar competition in Europe has played a vital role…
European patients need improved access to biosimilar… 22 April 2021 Fifteen years after the first global approval, biosimilar medicines systemically…
The European Commission needs to prioritise equitable access… 25 January 2022 Over 15 years ago, the world’s first biosimilar was launched.…
Position on the Proposal for a Regulation of the European… 19 June 2023 Medicines for Europe welcomes the introduction of harmonised labelling, notably…